WO1986006960A3 - Use of nicorandil or pinacidil for the treatment of peripheral vascular disease - Google Patents

Use of nicorandil or pinacidil for the treatment of peripheral vascular disease

Info

Publication number
WO1986006960A3
WO1986006960A3 PCT/GB1986/000282 GB8600282W WO8606960A3 WO 1986006960 A3 WO1986006960 A3 WO 1986006960A3 GB 8600282 W GB8600282 W GB 8600282W WO 8606960 A3 WO8606960 A3 WO 8606960A3
Authority
WO
WIPO (PCT)
Prior art keywords
pinacidil
nicorandil
treatment
vascular disease
peripheral vascular
Prior art date
Application number
PCT/GB1986/000282
Other languages
French (fr)
Other versions
WO1986006960A2 (en
Inventor
Charles David Nicholson
Dieter Angersbach
John Morris Evans
Original Assignee
Beecham Group Plc
Beecham Wuelfing Gmbh & Co Kg
Charles David Nicholson
Dieter Angersbach
John Morris Evans
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858512908A external-priority patent/GB8512908D0/en
Priority claimed from GB858513551A external-priority patent/GB8513551D0/en
Application filed by Beecham Group Plc, Beecham Wuelfing Gmbh & Co Kg, Charles David Nicholson, Dieter Angersbach, John Morris Evans filed Critical Beecham Group Plc
Publication of WO1986006960A2 publication Critical patent/WO1986006960A2/en
Publication of WO1986006960A3 publication Critical patent/WO1986006960A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Abstract

The use of nicorandil or pinacidil or a pharmaceutically acceptable salt or a hydrate thereof in the preparation of a medicament for the treatment of peripheral vascular disease.
PCT/GB1986/000282 1985-05-22 1986-05-20 Use of nicorandil or pinacidil for the treatment of peripheral vascular disease WO1986006960A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8512908 1985-05-22
GB858512908A GB8512908D0 (en) 1985-05-22 1985-05-22 Treatment
GB8513551 1985-05-29
GB858513551A GB8513551D0 (en) 1985-05-29 1985-05-29 Treatment

Publications (2)

Publication Number Publication Date
WO1986006960A2 WO1986006960A2 (en) 1986-12-04
WO1986006960A3 true WO1986006960A3 (en) 1987-01-29

Family

ID=26289278

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1986/000282 WO1986006960A2 (en) 1985-05-22 1986-05-20 Use of nicorandil or pinacidil for the treatment of peripheral vascular disease

Country Status (2)

Country Link
EP (1) EP0223811A1 (en)
WO (1) WO1986006960A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60601B1 (en) * 1986-08-27 1994-07-27 Chugai Pharmaceutical Co Ltd Therapeutic agent for the treatment of disorders associated with cerebral ischemia
GB8801318D0 (en) * 1988-01-21 1988-02-17 Leo Pharm Prod Ltd Pharmaceutical preparations
IT1256022B (en) * 1992-06-08 1995-11-20 STABLE PHARMACEUTICAL PREPARATIONS OF NICORANDIL
CN103260424B (en) 2010-12-20 2016-05-11 帝斯曼知识产权资产管理有限公司 Nitrooxy organic molecule reduces discharge of methane in ruminant and/or improves the purposes of ruminant performance in feed
US20200253926A1 (en) * 2019-02-13 2020-08-13 Supersalus, Inc. Therapeutic combinations

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714713A1 (en) * 1976-04-02 1977-10-20 Chugai Pharmaceutical Co Ltd PYRIDINE CARBOXAMIDE DERIVATIVES, METHOD FOR THEIR MANUFACTURING AND MEDICINAL PRODUCTS

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714713A1 (en) * 1976-04-02 1977-10-20 Chugai Pharmaceutical Co Ltd PYRIDINE CARBOXAMIDE DERIVATIVES, METHOD FOR THEIR MANUFACTURING AND MEDICINAL PRODUCTS

Also Published As

Publication number Publication date
WO1986006960A2 (en) 1986-12-04
EP0223811A1 (en) 1987-06-03

Similar Documents

Publication Publication Date Title
EP1029540A3 (en) Use of droloxifene for the treatment of cardiovascular diseases
AU649605B2 (en) Retinal, derivatives and their therapeutic use
HU912266D0 (en) Process for the production of solid medical preparations with controlled portioning of the active agents for oral use
AU2800689A (en) Differential delivery of therapeutic agents across the blood brain barrier
IE821214L (en) Medicament
AU650484B2 (en) Isoxazole compound, pharmaceutically acceptable salt thereof, and medicinal use thereof
AU1117092A (en) Treatment of lower urinary tract disorders
AU2807689A (en) Method for the treatment of body tissues and the administration of drugs thereto
WO2000008007A3 (en) Cyclopentabenzofuran derivatives and their use
EP0328924A3 (en) Thienotriazolodiazepine compounds and pharmaceutical uses thereof
WO1986006960A3 (en) Use of nicorandil or pinacidil for the treatment of peripheral vascular disease
AU3684395A (en) Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases
EP0437929A3 (en) Use of diadenosine-5',5'''-p1,p4-tetraphosphate for the manufacture of a medicament for the treatment of heart disease
NZ303993A (en) Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
CA2091134A1 (en) Therapeutic agent for threatened abortion
AU4476089A (en) Use of azepinone derivatives for the treatment of respiratory tract disorders
EP0193164A3 (en) Sustained-release pharmaceutical preparation which comprised 2-nitroxy-methyl-6-chloropyridine, process for its preparation and use thereof
IE873231L (en) Medicaments
AU2462097A (en) The use of a substance p antagonist for the manufacture of medicament for the treatment of ocular pain
CA2135752A1 (en) Use of (E)-2-(p-Fluorophenethyl)-3-Fluoroallylamine in the Treatment of Alzheimer's Disease
CA2167926A1 (en) Use of benzydamine in the treatment of pathological conditions caused by tnf
EP0357072A3 (en) Use of zofenopril for the preparation of drugs against rheumatoid arthritis
CA2069202A1 (en) The use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine in vascular surgery
WO1996027378A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
EP0418065A3 (en) Dihydrocaffeic acid derivatives, use thereof for medical treatments and pharmaceutical preparations containing same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BE CH DE FR GB IT NL

AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): BE CH DE FR GB IT NL

WWE Wipo information: entry into national phase

Ref document number: 1986903470

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1986903470

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1986903470

Country of ref document: EP